Marko Hyvönen

41PUBLICATIONS
168CO-AUTHORS
Molecular targetsBiologically active moleculesGlycoconjugatesClinical pharmacology and therapeuticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Aug 13, 2026
Selective Inhibition of CK2: Emerging Strategies and Future Directions.

|May 14, 2026
Targeting a Pleckstrin Homology Domain with a Lysine-Reactive Covalent Binder.

|Mar 24, 2026
Yeast Display Technology Enables Rapid Discovery of Low-Nanomolar Macrocyclic Peptide Inhibitors of Human Angiotensin-Converting Enzyme 2.

Zhanna Romanyuk, Giacomo Bettin, Paul Brear

|Feb 13, 2026
Utilizing Constrained Bicyclic Peptides for In Vitro Diagnostics.

André Shamsabadi, Adam Creamer, Christy J Sadler

|Oct 14, 2025
Exploiting the Cryptic αD Pocket of Casein Kinase 2α (CK2α) to Deliver Highly Potent and Selective Type 1 Inhibitors.

Paul A Glossop, Paul Brear, Susanne Wright

|Sep 16, 2025
Tumour-specific STING agonist synthesis via a two-component prodrug system.

Nai-Shu Hsu, Cong Tang, Raquel V Mendes

Pageof 7

Frequent Collaborators

16 joint publications

Paul D Brear

13 joint publications

David R Spring

6 joint publications

Florian Hollfelder

6 joint publications

Jessica Iegre